Forecasts data is unavailable for this security.
Consensus recommendation
- 18-May-23
- 15-Feb-24
- 14-Mar-24
- 18-Apr-24
- 09-May-24
Select bar for recommendation details.
Recommendations | 09-May-24 | |
---|---|---|
Buy | 11 | |
Outperform | 15 | |
Hold | 1 | |
Underperform | 0 | |
Sell | 0 |
Share price forecast in CNY
The 24 analysts offering 12 month price targets for Innovent Biologics Inc have a median target of 55.03, with a high estimate of 76.84 and a low estimate of 32.03. The median estimate represents a 39.50% increase from the last price of 39.45.
High | 94.8% | 76.84 |
Med | 39.5% | 55.03 |
Low | -18.8% | 32.03 |
Earnings history & estimates in CNY
Average growth rate | -1.65% |
More ▼
Revenue history & estimates in CNY
Average growth rate | +80.24% |
More ▼